Zero calcium score doesn’t equal zero coronary risk
High calcium scores are commonly considered a risk factor for coronary stenosis, but even a zero calcium score doesn’t assure coronary health in a high-risk population, a pair of papers presented Monday concluded.
High calcium scores are commonly considered a risk factor for coronary stenosis, but even a zero calcium score doesn't assure coronary health in a high-risk population, a pair of papers presented Monday concluded.
Studies from the Netherlands and China compared calcium scores against coronary stenosis in a high-risk population. In both studies, high calcium scores generally correlated with coronary stenosis. In a small subset, however, zero calcium scores did not assure the absence of coronary stenosis.
A study from the University Medical Center Groningen in the Netherlands found that patients with a zero coronary score had a 93% chance of not having coronary stenosis but could not rule out stenosis when the pretest probability was high.
The study included 160 patients. Most (96) were admitted for chest pain. The remaining 64 were considered to have a high cardiovascular risk profile.
Among the study set, 43 had zero calcium scores. CT angiography scans found that three of the 43 (7%) had significant stenosis.
The study also showed that patients without stenosis on CTA had a mean calcium score of 109 (Agatston scale). Those with one or more signs of stenosis on CTA had a mean calcium score of 1030.
The distribution of calcium scores was the following:
• zero, 37%
• 10 to 100, 13%
• 101 to 400, 18%
• more than 400, 36%
A study from Tuen Mun Hospital in Hong Kong examined 147 patients admitted for chest pain. Sixty-eight had zero calcium scores. Among those, four (5.9%) had significant stenosis on CTA. Another four had mild stenosis on CTA.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
